Last updated: 4 months ago
Achilles Therapeutics 6-K Report: Asset Sale to AstraZeneca & Strategic Update
Explore Achilles Therapeutics' 6-K filing detailing the sale of tech assets to AstraZeneca, strategic updates, and compliance with SEC regulations. Key insights included.